Ashley L. Dombkowski
Director/Board Member presso HUDSON EXECUTIVE INVESTMENT CORP. III
Profilo
Ashley L.
Dombkowski was the founder of iPierian, Inc. (founded in 2007), BEFORE Brands, Inc. (founded in 2015), and Alladapt Immunotherapeutics, Inc. (founded in 2018), where she held the titles of Director, Chief Executive Officer, and Chief Executive Officer & Director, respectively.
Currently, Dr. Dombkowski holds the position of Treasurer & Director at USA Volleyball and Independent Director at Hudson Executive Investment Corp.
III.
Dr. Dombkowski received a doctorate degree from Rice University in 1997 and an undergraduate degree from Wellesley College in 1992.
Posizioni attive di Ashley L. Dombkowski
| Società | Posizione | Inizio |
|---|---|---|
| HUDSON EXECUTIVE INVESTMENT CORP. III | Director/Board Member | 23/02/2021 |
Alladapt Immunotherapeutics, Inc.
 Alladapt Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alladapt Immunotherapeutics, Inc. operates as a biopharmaceutical company developing prescription therapeutics targeting food allergy. The company was founded by Ashley Dombkowski and Kari Nadeau in 2018 and is headquartered in Menlo Park, CA. | Founder | 01/01/2018 |
| USA Volleyball | Director/Board Member | - |
Precedenti posizioni note di Ashley L. Dombkowski
| Società | Posizione | Fine |
|---|---|---|
BEFORE Brands, Inc.
 BEFORE Brands, Inc. Food: Specialty/CandyConsumer Non-Durables BEFORE Brands, Inc. engages in the provision of pediatric nutritional products. It offers the SpoonfulOne, a line of childhood nutritional products designed to reduce food allergy development risk with key allergens. The company was founded by Ashley Ledbetter Dombkowski and Kari Nadeau in 2015 and is headquartered in Menlo Park, CA. | Chief Executive Officer | 04/12/2019 |
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Director/Board Member | 02/10/2012 |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Committee Member | - |
Restore Medical, Inc.
 Restore Medical, Inc. Medical SpecialtiesHealth Technology Restore Medical developed, manufactured and marketed pillar palatal implant systems used for the treatment of soft palate components of sleeps disordered breathing, obstructive sleep apnea, and snoring. The company was founded in 1999 and was headquartered in St. Paul, MN. | Director/Board Member | 22/05/2006 |
Tiger Management LLC
 Tiger Management LLC Investment ManagersFinance Tiger Management LLC is an independent hedge fund manager founded by Julian Robertson in 1980. Headquartered in New York City, the firm manages Mr. Robertson's personal assets. | Analyst-Equity | 31/12/1999 |
Formazione di Ashley L. Dombkowski
| Rice University | Doctorate Degree |
| Wellesley College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
Tiger Management LLC
Tiger Management LLC Investment ManagersFinance Tiger Management LLC is an independent hedge fund manager founded by Julian Robertson in 1980. Headquartered in New York City, the firm manages Mr. Robertson's personal assets. | Finance |
RCM Capital Management LLC
 RCM Capital Management LLC Investment ManagersFinance Founded in 1970 by Claude Rosenberg, RCM Capital Management LLC, formerly Rosenberg Capital Management, RCM Capital Management LLC is a registered investment advisor headquartered in San Francisco with additional offices in London, Frankfurt, Hong Kong, Tokyo and Sydney. The firm was also previously known as Dresdner RCM Global Investors. RCM is a division of RCM U.S. Holdings LLC and their ultimate parent is Allianz SE. RCM manages portfolios for individuals and institutions. They also manage the Allianz/Dresdner family of mutual funds. The firm provides investment management services to clients around the world including: pension funds, blue chip multinational companies, investment trusts, governments, insurance companies and charitable foundations. | Finance |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
Neosil, Inc.
 Neosil, Inc. Pharmaceuticals: MajorHealth Technology Neosil, Inc. manufactures pharmaceutical products. It develops hair growth products and anti-microbial agent for acne and anti-infective use. The company was founded by Sam Sawan in 2004 and is headquartered in Emeryvill, CA. | Health Technology |
Alnara Pharmaceuticals, Inc.
 Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | Health Technology |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
Restore Medical, Inc.
Restore Medical, Inc. Medical SpecialtiesHealth Technology Restore Medical developed, manufactured and marketed pillar palatal implant systems used for the treatment of soft palate components of sleeps disordered breathing, obstructive sleep apnea, and snoring. The company was founded in 1999 and was headquartered in St. Paul, MN. | Health Technology |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in San Rafael, California. | Finance |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
| USA Volleyball | |
iPierian, Inc.
 iPierian, Inc. Pharmaceuticals: MajorHealth Technology ierian, Inc. developed and manufactured biopharmaceutical products. The firm's lead antibody, IPN007, represents a new approach to treating neurodegenerative disease by targeting a novel form of secreted Tau protein. The company was founded in 2007 and is headquartered in South San Francisco, CA. | Health Technology |
BEFORE Brands, Inc.
BEFORE Brands, Inc. Food: Specialty/CandyConsumer Non-Durables BEFORE Brands, Inc. engages in the provision of pediatric nutritional products. It offers the SpoonfulOne, a line of childhood nutritional products designed to reduce food allergy development risk with key allergens. The company was founded by Ashley Ledbetter Dombkowski and Kari Nadeau in 2015 and is headquartered in Menlo Park, CA. | Consumer Non-Durables |
Alladapt Immunotherapeutics, Inc.
Alladapt Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alladapt Immunotherapeutics, Inc. operates as a biopharmaceutical company developing prescription therapeutics targeting food allergy. The company was founded by Ashley Dombkowski and Kari Nadeau in 2018 and is headquartered in Menlo Park, CA. | Health Technology |
Hudson Executive Investment Corp. III
 Hudson Executive Investment Corp. III Financial ConglomeratesFinance Hudson Executive Investment Corp. III operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Douglas Lee Braunstein and Douglas G. Bergeron on August 18, 2020 and is headquartered in New York, NY. | Finance |
- Borsa valori
- Insiders
- Ashley L. Dombkowski
